| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 05/21/2004 | WO2003102190A3 Bacterial polypeptides involved in viability |
| 05/21/2004 | WO2003089462A3 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 05/21/2004 | WO2003080638A3 Antisense iap nucleobase oligomers and uses thereof |
| 05/21/2004 | WO2003078601A8 Posh nucleic acids, polypeptides and related methods |
| 05/21/2004 | WO2003050275A8 Method of isolation and purification of trypsin from pronase and use thereof |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2003040296A8 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 05/21/2004 | WO2003023067A9 Binding phenol oxidizing enzyme-peptide complexes |
| 05/21/2004 | WO2002095014A9 Polypeptides having cellobiase activity and polynucleotides encoding same |
| 05/21/2004 | WO2002083869A9 Product and process for transformation of thraustochytriales microorganisms |
| 05/21/2004 | WO2002063025A8 Muscle-directed gene therapy with aav-1 and aav-6 vectors |
| 05/21/2004 | WO2002040674A9 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 05/21/2004 | CA2505707A1 Method of detecting bone paget's disease |
| 05/21/2004 | CA2505402A1 Method of preparing cross-linked enzyme particles |
| 05/21/2004 | CA2503965A1 Subtilase variants |
| 05/21/2004 | CA2502187A1 Method and system for creating a library of crosslinked enzyme aggregates |
| 05/21/2004 | CA2502184A1 Improved crosslinked enzyme aggregates |
| 05/20/2004 | US20040098762 Comprises nucleotide sequences coding desaturase for insertion of a double bond into a fatty acyl moiety at the twelfth or fifteenth carbon position in fatty acyl chain; improving vegetable oils |
| 05/20/2004 | US20040098761 Compositions and methods for controlling parasitic nematodes |
| 05/20/2004 | US20040098759 Comprises expression vector coding nucleotide sequences for heavy metal transporting P type membrane pump protein for transformation and propagation of crops resistant to heavy metal poisoning and uptake; bioremediation |
| 05/20/2004 | US20040098756 Transgenic animals for use in protein expression and antibody production |
| 05/20/2004 | US20040097720 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
| 05/20/2004 | US20040097717 Comprises nucleotide sequences coding polypeptide associated with abscisic acid (ABA) biosynthesis and for controlling preharvest sprouting in plants; agriculture and genetic engineering |
| 05/20/2004 | US20040097458 Providing microprojectiles carrying polynucleic acid sequences; accelerating the microprojectiles at the preselected-cells, with the microprojectiles contacting cells to penetrate vertebrate cells and deposit polynucleic acid |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings |
| 05/20/2004 | US20040097439 Useful to study, increase and/or reduce genes expression, and to improve DNA vaccination |
| 05/20/2004 | US20040097420 Proteasome regulation of NF-kB activity |
| 05/20/2004 | US20040097409 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 05/20/2004 | US20040097393 Use of a single cellulase with a ratio of tensile strength loss to antipilling properties in aqueous laundry solutions |
| 05/20/2004 | US20040096955 Methods and compositions for determining isomerase enzymatic activity |
| 05/20/2004 | US20040096953 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing composition, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same, |
| 05/20/2004 | US20040096952 Alpha-amylase variant with altered properties |
| 05/20/2004 | US20040096951 Crystal structures of retaining glycosytransferases |
| 05/20/2004 | US20040096950 Crystal structure of beta site APP cleaving enzyme (BACE) and methods of use thereof |
| 05/20/2004 | US20040096949 Novel motor proteins and methods for their use |
| 05/20/2004 | US20040096946 Escherichia culture product; genetic engineered erythronolide antibiotics |
| 05/20/2004 | US20040096944 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 05/20/2004 | US20040096938 Method for generating split, non-transferable genes that are able to express an active protein product |
| 05/20/2004 | US20040096932 Enzyme catalysis in the presence of ionic liquids |
| 05/20/2004 | US20040096929 Enzymatic cycling assays for homocysteine and cystathionine |
| 05/20/2004 | US20040096925 Identifying enzyme inhibitors for treatment of skin, allergic and inflammatory disorders; cosmetics |
| 05/20/2004 | US20040096921 Human plasma hyaluronidase |
| 05/20/2004 | US20040096890 Compositions, organisms and methodologies employing a novel human kinase |
| 05/20/2004 | US20040096889 Compositions, organisms and methodologies employing a novel human kinase |
| 05/20/2004 | US20040096881 For prophylactics/diagnostics/therapeutics; endothelial nitric oxide synthase (eNOS) |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096874 Characterization of CYP 2D6 genotypes |
| 05/20/2004 | US20040096868 For diagnosis/treatment of cancer; drugs; kits; cell-free analysis; solid phase synthesis |
| 05/20/2004 | US20040096865 For diagnosis/preventing/treating central nervous system disorders/obesity/diabetes; cell-free; solid phase synthesis; kits |
| 05/20/2004 | US20040096862 Novel protein and dna encoding the same |
| 05/20/2004 | US20040096858 For diagnosing/treating/preventing genetic/cardiovascular/ vision/reproductive/smooth muscle disorders; polymerase chain reaction (PCR); genetic engineering |
| 05/20/2004 | US20040096850 For decreasing the phosphorus waste derived from monogastric animal nutrition; feeds |
| 05/20/2004 | US20040096841 Novel polypeptide-phosphatidic acid phsphatase 29.81 and the polynucleotide encoding said polypeptide |
| 05/20/2004 | US20040096819 Method for quantitative analysis of a nucleic acid amplification reaction |
| 05/20/2004 | US20040096818 Gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries |
| 05/20/2004 | US20040096452 Multivalent vaccines for the treatment of B-cell malignancies (e.g., lymphomas and leukemias) . The present invention also provides methods for the production of custom vaccines, including multivalent vaccines for the treatment of immune |
| 05/20/2004 | US20040096448 Nucleic acid molecules encoding a protein interacting with ser/thr kinase akt |
| 05/20/2004 | US20040096443 Treatment of neurodegenerative diseases and conditions using par1 antagonists |
| 05/20/2004 | US20040096437 Pharmaceutical composition comprising arginine deiminasa for inhibiting angio-genesis |
| 05/20/2004 | US20040096435 Methods for screening compounds that modulate lipid metabolism |
| 05/19/2004 | EP1420067A1 Chondroitin synthase |
| 05/19/2004 | EP1419392A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 05/19/2004 | EP1419276A2 Diagnosis and treatment of diseases associated with altered expression of hipk1 |
| 05/19/2004 | EP1419267A2 Methods and means of histone methylation |
| 05/19/2004 | EP1419265A2 Gene associated with bone disorders |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419263A2 Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same |
| 05/19/2004 | EP1419258A2 Plasmids from an extremely thermophilic microorganism and derived expression vectors |
| 05/19/2004 | EP1419255A2 A novel group of $g(a)-amylases and a method for identification and production of novel $g(a)-amylases |
| 05/19/2004 | EP1419253A2 Isolation of proteins involved in posttranscriptional gene silencing and methods of use |
| 05/19/2004 | EP1419246A2 A method for identifying constitutively active mutants of mitogen activated protein kinases (mapk) and uses thereof |
| 05/19/2004 | EP1419243A1 A method for immobilizing molecules with physiological activity |
| 05/19/2004 | EP1419242A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/19/2004 | EP1419241A2 Improved nitroreductase enzymes |
| 05/19/2004 | EP1419237A2 Animal model for fatty acid amide-related neurobehaviors |
| 05/19/2004 | EP1418944A2 Dsp-18 dual-specificity phosphatase |
| 05/19/2004 | EP1418813A2 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 05/19/2004 | EP1418803A1 Alteration of embryo/endosperm size during seed development |
| 05/19/2004 | EP1294942A4 Genetic typing of the human cytochrome p450 2a6 gene and related materials and methods |
| 05/19/2004 | EP1200478A4 Method for assaying compounds affecting smooth muscle contractile state |
| 05/19/2004 | EP0920493B1 Biodegradation of explosives |
| 05/19/2004 | EP0851913B1 Novel lipolytic enzymes |
| 05/19/2004 | EP0818138B1 Method for creating osmotic-pressure-tolerant plant |
| 05/19/2004 | EP0814155B1 Calcium-requiring, prothrombin-activating enzyme |
| 05/19/2004 | EP0650525B1 D-n-carbamoyl-amino acid amidohydrolase and hydantoinase |
| 05/19/2004 | DE10251747A1 Gentechnisch veränderte Penicillinamidase und Verfahren zu ihrer Herstellung Genetically modified penicillin and process for their preparation |
| 05/19/2004 | DE10251547A1 New R-hydroxynitrile lyase, useful for synthesis of chiral cyanohydrins, e.g. intermediates for pyrethroids, also nucleic acid encoding it, is shortened form of the almond enzyme |
| 05/19/2004 | CN1498270A Gene disrupted yeast |
| 05/19/2004 | CN1498268A Enzymes coated with ionic liquid |
| 05/19/2004 | CN1498226A Thrombin derivatives and its process for production, anhydrothrombin derivatives and its production method, platelet agglutination-inducing compositions, method of inducing platelet agglutination,... |
| 05/19/2004 | CN1498223A Anti-angiogenic polyeptides |
| 05/19/2004 | CN1497047A Expression system for producing recombination tryptophanase and preparation method and application of recombination tryptophanase |
| 05/19/2004 | CN1497046A Alpha ketonic acid reductase and its preparation method, and method of preparing optical active alpha hydroxy acid using said reductase |
| 05/19/2004 | CN1150329C Netatode-inducible regulatory DNA Sequences |
| 05/19/2004 | CN1150326C Mutant of human tissue type plasminogen activator |
| 05/19/2004 | CN1150325C DNA molecules of aminopeptidase with code and production of the aminopeptidase |
| 05/19/2004 | CN1150324C Novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
| 05/19/2004 | CN1150323C Gene for enzyme having both alkaline pullulanse and alkaline alpha-amylase activities |
| 05/19/2004 | CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |